Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Bee Vectoring Technologies and BioSafe Systems start selling CR-7 products into foliar and soil drench markets

Bee Vectoring Technologies International Inc. and BioSafe Systems jointly announced a signed commercial agreement. BioSafe Systems, an industry leader in environmentally sustainable products, will offer a range of products based on BVT’s Clonostachys rosea CR-7 (CR-7) proprietary microbe for use in foliar and soil drench markets in the United States, with future options to expand into Mexico and other countries.

“This partnership with BioSafe is part of our corporate strategy to accelerate growth in new markets – both geographically and with product offerings beyond our core bee-vectoring applications,” said Ashish Malik, CEO of BVT. “It follows our January 2022 announcement of the MOU with BioSafe, and now has successfully moved into a commercial agreement after completing discussions and evaluations.”

“This is a significant development for the Company as it provides an opportunity to showcase the new range of our assets that can be scaled for a number of commercial applications,” continued Mr. Malik. “Our CR-7 franchise extends our Company’s reach beyond bee vectoring distribution and into the much larger market for foliar and soil-applied crop protection products. Furthermore, this method of application is the standard in the ag industry, and thus we anticipate broader acceptance of the bee delivery program as well as growers witnessing the benefits of CR-7 firsthand. This agreement with an established player in the US market is the first step in our initiative to provide CR-7-based solutions to farmers through partnering companies that have large sales and marketing capabilities.”

BVT will provide technical grade CR-7 on a non-exclusive basis to BioSafe, who will develop and market end-use biological products for plant health and control of foliar and soil diseases. The new end-use products will build upon the expertise of both companies, which have agreed to collaborate closely to expedite the time to market on all formulations and obtain any necessary regulatory requirements. The first product is expected to enter the market as early as the 2023 growing season.

“BioSafe has a 23-year history as an innovator and industry leader of environmentally sustainable products, with an established distribution channel serving a broad customer base in the agriculture, greenhouse (including cannabis production), horticulture, post-harvest/food safety, aquatics, home and garden, turf, and commercial/industrial sanitation markets,” continued Mr. Malik. “They enable BVT to expand our product reach beyond bee vectoring on both food and non-food crops. We are excited to be working with them to expand farmers’ options in natural disease control. Both companies are focused on having the product demonstrated during the 2023 growing season.”

“Our company has very high environmental and sustainability standards,” said Lauren Crane, President at BioSafe. “BVT meets these criteria perfectly – after extensive testing, we are pleased with the high efficacy and overall performance of CR-7 and look forward to offering innovative solutions based on CR-7 to our clients.”

“We are confident that as BVT expands CR-7 registrations in other countries like Mexico, Canada, and the EU, a successful demonstration of foliar and soil drenching in the US will garner further interest in BVT products for the countries that present access to large, sophisticated growers,” continued Mr. Malik. “BVT is committed to continually developing the use of our proprietary CR-7 in all application methods, and this agreement allows the Company to leverage established relationships to scale our growth and market share.”

The global market for fungicides, which includes foliar and soil-applied fungicides, is approximately US $20 billion currently and expected to grow at a compound annual growth rate (CAGR) of 6.8%(1) with the North American market estimated to be US $5 billion. (2) Foliar spray application of fungicides is used to manage a multitude of plant diseases above the soil throughout the growing season that can affect the yields of crops. Soil drench applications are used to manage soil pathogens that affect the roots of plants and can provide systemic protection as well as crop health and enhancements.

For more information:
Bee Vectoring Technologies International Inc.
Tel.: (647) 660-5119     

Publication date: